Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib

Abstract excerpt

OBJECT: The authors have previously reported that erlotinib, an EGFR tyrosine kinase inhibitor, exerts widely variable antiproliferative effects on 9 human glioblastoma multiforme (GBM) cell lines in vitro and in vivo. These effects were independent of EGFR baseline expression levels, raising the possibility that more complex genetic properties form the molecular basis of the erlotinib-sensitive and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glioma Diagnosis and Treatment
• Share to HER2/EGFR in Cancer Research
• Share to Peptidase Inhibition and Analysis